Valiant Laboratories Ltd. (IN:VALIANTLAB)
:VALIANTLAB
Want to see IN:VALIANTLAB full AI Analyst Report?
Total Valuation
Valiant Laboratories Ltd. has a market cap or net worth of ₹4.44B. The enterprise value is ₹4.94B.
Market Cap₹4.44B
Enterprise Value₹4.94B
Share Statistics
Valiant Laboratories Ltd. has 54,312,500 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding54,312,500
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Valiant Laboratories Ltd.’s return on equity (ROE) is >-0.01 and return on invested capital (ROIC) is 4.98%.
Return on Equity (ROE)>-0.01
Return on Assets (ROA)>-0.01
Return on Invested Capital (ROIC)4.98%
Return on Capital Employed (ROCE)0.05
Revenue Per Employee18.03M
Profits Per Employee-285.87K
Employee Count77
Asset Turnover0.35
Inventory Turnover29.23
Valuation Ratios
The current PE Ratio of Valiant Laboratories Ltd. is ―. Valiant Laboratories Ltd.’s PEG ratio is 0.22.
PE Ratio―
PS Ratio2.47
PB Ratio1.46
Price to Fair Value1.46
Price to FCF-3.04
Price to Operating Cash Flow-77.48
PEG Ratio0.22
Income Statement
In the last 12 months, Valiant Laboratories Ltd. had revenue of 1.39B and earned -22.01M in profits. Earnings per share was -0.51.
Revenue1.39B
Gross Profit222.17M
Operating Income178.29M
Pretax Income-15.13M
Net Income-22.01M
EBITDA7.55M
Earnings Per Share (EPS)-0.51
Cash Flow
In the last 12 months, operating cash flow was -57.24M and capital expenditures -1.33B, giving a free cash flow of -1.39B billion.
Operating Cash Flow-57.24M
Free Cash Flow-1.39B
Free Cash Flow per Share-25.52
Dividends & Yields
Valiant Laboratories Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.77
52-Week Price Change-11.85%
50-Day Moving Average58.25
200-Day Moving Average76.37
Relative Strength Index (RSI)67.71
Average Volume (3m)1.58K
Important Dates
Valiant Laboratories Ltd. upcoming earnings date is May 19, 2026, Before Open (Confirmed).
Last Earnings DateFeb 11, 2026
Next Earnings DateMay 19, 2026
Ex-Dividend Date―
Financial Position
Valiant Laboratories Ltd. as a current ratio of 3.23, with Debt / Equity ratio of 16.94%
Current Ratio3.23
Quick Ratio3.16
Debt to Market Cap0.35
Net Debt to EBITDA154.58
Interest Coverage Ratio101.71
Taxes
In the past 12 months, Valiant Laboratories Ltd. has paid 6.89M in taxes.
Income Tax6.89M
Effective Tax Rate-0.46
Enterprise Valuation
Valiant Laboratories Ltd. EV to EBITDA ratio is 608.01, with an EV/FCF ratio of -4.08.
EV to Sales3.31
EV to EBITDA608.01
EV to Free Cash Flow-4.08
EV to Operating Cash Flow349.73
Balance Sheet
Valiant Laboratories Ltd. has ₹629.06M in cash and marketable securities with ₹537.68M in debt, giving a net cash position of ₹91.37M billion.
Cash & Marketable Securities₹629.06M
Total Debt₹537.68M
Net Cash₹91.37M
Net Cash Per Share₹1.68
Tangible Book Value Per Share₹54.26
Margins
Gross margin is 11.80%, with operating margin of 12.84%, and net profit margin of -1.59%.
Gross Margin11.80%
Operating Margin12.84%
Pretax Margin-1.09%
Net Profit Margin-1.59%
EBITDA Margin0.54%
EBIT Margin-0.96%
Analyst Forecast
The average price target for Valiant Laboratories Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast91.43%
EPS Growth Forecast18.68%